India  

COVAXIN has shown less than 10% adverse reactions: Bharat Biotech MD

Video Credit: ANI - Duration: 01:42s - Published
COVAXIN has shown less than 10% adverse reactions: Bharat Biotech MD

COVAXIN has shown less than 10% adverse reactions: Bharat Biotech MD

While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna M Ella said, "COVAXIN has shown less than 10% adverse reactions, while others have 60-70% adverse reactions.

AstraZeneca was giving 4g of paracetamol to volunteers to suppress such reactions.

We haven't given paracetamol to any volunteer."


You Might Like


💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Chhattisgarh will receive 3.50 lakh doses of Covishield today [Video]

Chhattisgarh will receive 3.50 lakh doses of Covishield today

Health Minister of Chhattisgarh, TS Singh Deo on May 08 said the state government will receive 3.50 lakh doses of Covishield today and the further vaccination will go on with this. "We received 1.50 lakh Covaxin doses from Bharat Biotech on May 1 and the vaccination is going on with that. We'll receive 3.50 lakh doses of Covishield today and the vaccination will further go on with this," Deo said media persons.

Credit: ANI    Duration: 01:25Published

Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says government

The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid..
IndiaTimes

Media reports alleging Centre hasn't placed any fresh order for Covid-19 vaccines incorrect: Health ministry

"The news reports suggest that the last order placed with the two vaccine makers (100 million doses with SII and 20 million doses with Bharat Biotech) was in..
IndiaTimes
India receives first lot of Sputnik V vaccine [Video]

India receives first lot of Sputnik V vaccine

India on May 01 got the first lot of Russia's Sputnik V vaccine. The shipment arrived at the Hyderabad airport where Indian authorities received the first batch of 1.5 lakh doses of the Russia-made vaccines. India now has three vaccines - Covishield by Serum Institute of India, Covaxin by Bharat Biotech and Russia's Sputnik V. Sputnik V was given emergency use authorisation by the Indian government last month.

Credit: ANI    Duration: 02:00Published

Hyderabad Hyderabad Capital of Telangana, India

Hyderabad's Calvary Temple turns into 300-bed COVID care centre [Video]

Hyderabad's Calvary Temple turns into 300-bed COVID care centre

With upsurge in country's COVID-19 cases, many organisations have come forward to offer their best during these tough times. Telangana's Calvary Temple has been converted into a COVID care centre. The 300-bed capacity centre was inaugurated by TRS leader and MLC K Kavitha. It is a highly equipped centre with oxygen support and has round the clock presence of doctors and nurses. The temple association is looking forward to further increase the bed capacity to 1,000 in coming days.

Credit: ANI    Duration: 01:50Published
Watch: Portable oxygen generator made by Hyderabad start-up amid Covid crisis [Video]

Watch: Portable oxygen generator made by Hyderabad start-up amid Covid crisis

A Hyderabad-based start-up claims to have developed a portable and affordable oxygen generator. India is currently facing an acute shortage of medical oxygen amid a huge rise in Covid-19 cases. The Phi Factory co-founder Praveen Gorakavi said that the machine can support two patients for six hours, or one for twelve hours. It can prove to be crucial in saving lives while patients await medical care. Watch the full video for more.

Credit: HT Digital Content    Duration: 02:45Published
COVID: Hyderabad start-up invents affordable oxygenator to address oxygen crisis [Video]

COVID: Hyderabad start-up invents affordable oxygenator to address oxygen crisis

As the country is reeling under the horrific second wave of pandemic and acute oxygen shortage, a start-up in Hyderabad came up with a invention to address the crisis. 'The Phi Factory' has created a portable oxygenerator, which works on Hydrogen Peroxide, under the name 'Project Vayuputra'. Vayuputra has been developed with an objective to support COVID-19 patients who are under home isolation. Price of this oxygenerator would be around Rs. 2,500 to Rs. 2,600 that includes the oxygenerator along with 10x2 liter bottles of Hydrogen Peroxide.

Credit: ANI    Duration: 02:40Published

BBV152 BBV152 Vaccine against COVID-19

1 lakh inoculated so far in 18-44 age groups: Rajesh Tope [Video]

1 lakh inoculated so far in 18-44 age groups: Rajesh Tope

Speaking on COVID-19 situation in Maharashtra, State Health Minister Rajesh Tope on May 04 said, "Few centres were closed yesterday due to doses' shortage. Got 9 lakh vials today, to last for 2-3 days. 1 lakh inoculated so far in 18-44 age groups. Order placed for 18.5 lakh vaccines (Covishield and Covaxin).

Credit: ANI    Duration: 01:40Published
Vaccine single dose: Is it efficient? Studies say this...| Oneindia News [Video]

Vaccine single dose: Is it efficient? Studies say this...| Oneindia News

While it must be understood that taking both doses of any vaccine whether it be Covishield, Covaxin or Sputnik, the ones that are available in India, are critical, here is what we know about one dose vaccine efficiency. #Vaccine #SingleDose #Explained

Credit: Oneindia    Duration: 01:30Published

AstraZeneca British-Swedish pharmaceutical company

Age threshold for alternative to AstraZeneca jab raised [Video]

Age threshold for alternative to AstraZeneca jab raised

Under-40s are to be offered an alternative to the Oxford/AstraZeneca Covid-19 vaccine as a precautionary move.

Credit: PA - Press Association STUDIO    Duration: 00:38Published
Under-40s in UK to get alternative Covid jab to AstraZeneca [Video]

Under-40s in UK to get alternative Covid jab to AstraZeneca

Under-40s in the UK will be offered an alternative coronavirus vaccine to the Oxford/AstraZeneca jab. The Joint Committee on Vaccination and Immunisation (JCVI) said there is an "extremely small risk" of people suffering blood clots after having the jab. Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:00Published

Under-40s to be offered alternative to Oxford jab over blood clot fears

All under-40s are to be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine as a precaution.
Sky News
Vaccine production is truly international collaboration in India: EAM [Video]

Vaccine production is truly international collaboration in India: EAM

Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other countries. On what basis Covishield was being made in India? It's Oxford-AstraZeneca vaccine, you can say it's British-designed product. It was made in India as the vaccine owner saw India as an efficient production venue. Along with that the ability and approval to make in India, came an obligation to supply it to a large part of the world. So, people have to understand, it was not that vaccine production started in India, it was invented by an Indian, owned by an Indian, produced by an Indian." He further said, "It was a truly international collaboration. When there is an international collaboration, if somebody gave you a vaccine to make in India, then you have to do your part, otherwise, it doesn't work. It also came with support from the Covax initiative. So, there was an obligation to support the Covax initiative to give vaccines at a low cost to a number of nations."

Credit: ANI    Duration: 01:57Published

US 'doing a lot for India' to meet Covid crisis: Joe Biden

President Joe Biden has said that the US was "doing a lot for India" by sending it oxygen and materials to make anti-Covid-19 vaccines. Biden's spokesperson Jen..
IndiaTimes

Related news from verified sources

Who shouldn't take Covaxin shot right now?

Considering the adverse reactions, Bharat Biotech has now released a factsheet, detailing the people...
IndiaTimes - Published


Related videos from verified sources

Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi...

Credit: HT Digital Content     Duration: 06:46Published
Bharat Biotech's consent form for Covaxin recipients says...| Oneindia News [Video]

Bharat Biotech's consent form for Covaxin recipients says...| Oneindia News

Bharat Biotech has said that it will pay recipients of the vaccine Covaxin compensation if beneficiaries face any adverse effects after taking it while the vaccine remains in clinical trial mode. Watch..

Credit: Oneindia     Duration: 01:05Published